Skip to main content
Log in

Epothilone B and its Derivatives as Novel Antitumor Drugs: Total and Partial Synthesis and Biological Evaluation

  • Invited Review
  • Published:
Monatshefte für Chemie / Chemical Monthly Aims and scope Submit manuscript

Summary.

 Microtubule stabilizing natural products, as exemplified by paclitaxel (taxol®), are being considered as novel drugs against malignant therapy resistent solid tumors. Among these compounds, epothilone B and some of its derivatives have emerged as particularly promising candidates for industrial development. The total and partial syntheses of these compounds are described in detail, and some of the most important recent results on their biological activity are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received December 3, 1999. Accepted December 6, 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mulzer, J. Epothilone B and its Derivatives as Novel Antitumor Drugs: Total and Partial Synthesis and Biological Evaluation. Monatshefte für Chemie 131, 205–238 (2000). https://doi.org/10.1007/s007060070099

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s007060070099

Navigation